What are Oncogenes?
Oncogenes are mutated forms of normal genes known as
proto-oncogenes. In their normal state, proto-oncogenes play a crucial role in regulating cell growth and
differentiation. However, when these genes undergo mutations or are expressed at high levels, they become oncogenes and can drive the uncontrolled cell proliferation characteristic of
cancer.
How Do Oncogenes Contribute to Cancer?
Oncogenes contribute to cancer by promoting unregulated cell division. This can happen through various mechanisms such as point mutations, gene amplification, or chromosomal translocations. For example, the
Ras gene, when mutated, can continuously signal cells to divide without the presence of growth factors. Similarly, the
MYC gene can become overexpressed and drive rapid cell proliferation.
What are Tumor Suppressor Genes?
Tumor suppressor genes are a class of genes that help regulate cell growth by inhibiting cell division, repairing DNA mistakes, or initiating apoptosis (programmed cell death). They act as a safeguard against uncontrolled cell proliferation. Well-known tumor suppressor genes include
TP53 and
RB1.
How Do Tumor Suppressor Genes Prevent Cancer?
Tumor suppressor genes prevent cancer by keeping cell division in check and maintaining genomic stability. For instance, the TP53 gene encodes the p53 protein, which can activate DNA repair proteins, initiate apoptosis, and halt the cell cycle to prevent the propagation of damaged DNA. The RB1 gene produces the Rb protein, which regulates the cell cycle by preventing cells from prematurely entering the S phase.
What Happens When Tumor Suppressor Genes are Mutated?
When tumor suppressor genes are mutated or deleted, their regulatory functions are lost. This loss of function can lead to unrestrained cell division and contribute to tumorigenesis. For example, mutations in the TP53 gene are found in more than 50% of all human cancers, making it one of the most common mutations in cancer.
How Do Oncogenes and Tumor Suppressor Genes Interact?
Oncogenes and tumor suppressor genes often interact in complex ways during the development of cancer. The activation of oncogenes can lead to increased cell proliferation, while the inactivation of tumor suppressor genes removes the brakes on this proliferation. This dual effect can create a cellular environment that is highly conducive to the formation and progression of cancer.
Can These Genes Be Therapeutic Targets?
Yes, both oncogenes and tumor suppressor genes can be targeted for cancer therapy. For example, drugs like
imatinib (Gleevec) specifically inhibit the BCR-ABL fusion protein, an oncogene product in chronic myeloid leukemia. Similarly, restoring the function of mutated tumor suppressor genes or mimicking their activity is a promising area of research, although it is technically more challenging.
Some well-known tumor suppressor genes include:
-
BRCA1/BRCA2: Mutations are associated with breast and ovarian cancers.
-
APC: Mutations are linked to colorectal cancer.
-
PTEN: Mutations are found in various cancers, including prostate and endometrial cancers.
Conclusion
Understanding the roles of oncogenes and tumor suppressor genes is essential in the study of cancer biology. These genes are pivotal in the regulation of cell growth, and their dysregulation is a hallmark of cancer. Advances in research continue to unravel the complexities of these genes, paving the way for more effective diagnostic and therapeutic strategies.
